+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Inflammatory Therapeutics Market 2024-2028

  • PDF Icon

    Report

  • 174 Pages
  • May 2024
  • Region: Global
  • TechNavio
  • ID: 5008905
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The anti-inflammatory therapeutics market is forecasted to grow by USD 38.7 billion during 2023-2028, accelerating at a CAGR of 6.3% during the forecast period. The report on the anti-inflammatory therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in off-label use, unmet needs for safer biologics for RA, and availability of improved diagnostic modalities.

The anti-inflammatory therapeutics market is segmented as below:

By Application

  • RA
  • Psoriasis
  • MS

By Drug Class

  • Anti-inflammatory biologicals
  • Corticosteroids
  • NSAIDs

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the emergence of novel anti-inflammatory drugs as one of the prime reasons driving the anti-inflammatory therapeutics market growth during the next few years. Also, use of gene therapy for RA treatment and market dominance by tnf-alpha inhibitors will lead to sizable demand in the market.

The report on the anti-inflammatory therapeutics market covers the following areas:

  • Anti-inflammatory therapeutics market sizing
  • Anti-inflammatory therapeutics market forecast
  • Anti-inflammatory therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anti-inflammatory therapeutics market vendors that include AbbVie Inc., Alvogen Iceland ehf, Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Cadila Pharmaceuticals Ltd., Cipla Inc., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Ferring BV, GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Lupin Ltd., Viatris Inc., Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., and Novartis AG. Also, the anti-inflammatory therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Anti-Inflammatory Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Anti-Inflammatory Therapeutics Market 2018 - 2022 ($ billion)
4.2 Application segment analysis 2018 - 2022
Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.3 Drug Class segment analysis 2018 - 2022
Historic Market Size - Drug Class Segment 2018 - 2022 ($ billion)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Chart on Application - Market share 2023-2028 (%)
Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
6.3 RA - Market size and forecast 2023-2028
Chart on RA - Market size and forecast 2023-2028 ($ billion)
Data Table on RA - Market size and forecast 2023-2028 ($ billion)
Chart on RA - Year-over-year growth 2023-2028 (%)
Data Table on RA - Year-over-year growth 2023-2028 (%)
6.4 Psoriasis - Market size and forecast 2023-2028
Chart on Psoriasis - Market size and forecast 2023-2028 ($ billion)
Data Table on Psoriasis - Market size and forecast 2023-2028 ($ billion)
Chart on Psoriasis - Year-over-year growth 2023-2028 (%)
Data Table on Psoriasis - Year-over-year growth 2023-2028 (%)
6.5 MS - Market size and forecast 2023-2028
Chart on MS - Market size and forecast 2023-2028 ($ billion)
Data Table on MS - Market size and forecast 2023-2028 ($ billion)
Chart on MS - Year-over-year growth 2023-2028 (%)
Data Table on MS - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Application
Market opportunity by Application ($ billion)
Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by Drug Class
7.1 Market segments
Chart on Drug Class - Market share 2023-2028 (%)
Data Table on Drug Class - Market share 2023-2028 (%)
7.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
7.3 Anti-inflammatory biologicals - Market size and forecast 2023-2028
Chart on Anti-inflammatory biologicals - Market size and forecast 2023-2028 ($ billion)
Data Table on Anti-inflammatory biologicals - Market size and forecast 2023-2028 ($ billion)
Chart on Anti-inflammatory biologicals - Year-over-year growth 2023-2028 (%)
Data Table on Anti-inflammatory biologicals - Year-over-year growth 2023-2028 (%)
7.4 Corticosteroids - Market size and forecast 2023-2028
Chart on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
Data Table on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
Chart on Corticosteroids - Year-over-year growth 2023-2028 (%)
Data Table on Corticosteroids - Year-over-year growth 2023-2028 (%)
7.5 NSAIDs - Market size and forecast 2023-2028
Chart on NSAIDs - Market size and forecast 2023-2028 ($ billion)
Data Table on NSAIDs - Market size and forecast 2023-2028 ($ billion)
Chart on NSAIDs - Year-over-year growth 2023-2028 (%)
Data Table on NSAIDs - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Drug Class
Market opportunity by Drug Class ($ billion)
Data Table on Market opportunity by Drug Class ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape2023-2028 (%)
Data Table on Market share By Geographical Landscape2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ billion)
Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ billion)
Data Table on US - Market size and forecast 2023-2028 ($ billion)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ billion)
Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ billion)
Data Table on China - Market size and forecast 2023-2028 ($ billion)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity By Geographical Landscape($ billion)
Data Tables on Market opportunity By Geographical Landscape($ billion)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 Alvogen Iceland ehf
Alvogen Iceland ehf - Overview
Alvogen Iceland ehf - Product / Service
Alvogen Iceland ehf - Key offerings
12.5 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key offerings
12.6 Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc. - Overview
Amneal Pharmaceuticals Inc. - Business segments
Amneal Pharmaceuticals Inc. - Key news
Amneal Pharmaceuticals Inc. - Key offerings
Amneal Pharmaceuticals Inc. - Segment focus
12.7 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.8 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.9 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.10 F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. - Overview
F. Hoffmann-La Roche Ltd. - Product / Service
F. Hoffmann-La Roche Ltd. - Key offerings
12.11 Ferring BV
Ferring BV - Overview
Ferring BV - Product / Service
Ferring BV - Key offerings
12.12 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.13 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Anti-Inflammatory Therapeutics Market 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Drug Class Segment 2018 - 2022 ($ billion)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Application - Market share 2023-2028 (%)
Exhibits 33: Data Table on Application - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Application
Exhibits 35: Data Table on Comparison by Application
Exhibits 36: Chart on RA - Market size and forecast 2023-2028 ($ billion)
Exhibits 37: Data Table on RA - Market size and forecast 2023-2028 ($ billion)
Exhibits 38: Chart on RA - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on RA - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Psoriasis - Market size and forecast 2023-2028 ($ billion)
Exhibits 41: Data Table on Psoriasis - Market size and forecast 2023-2028 ($ billion)
Exhibits 42: Chart on Psoriasis - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Psoriasis - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on MS - Market size and forecast 2023-2028 ($ billion)
Exhibits 45: Data Table on MS - Market size and forecast 2023-2028 ($ billion)
Exhibits 46: Chart on MS - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on MS - Year-over-year growth 2023-2028 (%)
Exhibits 48: Market opportunity by Application ($ billion)
Exhibits 49: Data Table on Market opportunity by Application ($ billion)
Exhibits 50: Chart on Drug Class - Market share 2023-2028 (%)
Exhibits 51: Data Table on Drug Class - Market share 2023-2028 (%)
Exhibits 52: Chart on Comparison by Drug Class
Exhibits 53: Data Table on Comparison by Drug Class
Exhibits 54: Chart on Anti-inflammatory biologicals - Market size and forecast 2023-2028 ($ billion)
Exhibits 55: Data Table on Anti-inflammatory biologicals - Market size and forecast 2023-2028 ($ billion)
Exhibits 56: Chart on Anti-inflammatory biologicals - Year-over-year growth 2023-2028 (%)
Exhibits 57: Data Table on Anti-inflammatory biologicals - Year-over-year growth 2023-2028 (%)
Exhibits 58: Chart on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
Exhibits 59: Data Table on Corticosteroids - Market size and forecast 2023-2028 ($ billion)
Exhibits 60: Chart on Corticosteroids - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Corticosteroids - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on NSAIDs - Market size and forecast 2023-2028 ($ billion)
Exhibits 63: Data Table on NSAIDs - Market size and forecast 2023-2028 ($ billion)
Exhibits 64: Chart on NSAIDs - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on NSAIDs - Year-over-year growth 2023-2028 (%)
Exhibits 66: Market opportunity by Drug Class ($ billion)
Exhibits 67: Data Table on Market opportunity by Drug Class ($ billion)
Exhibits 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 69: Chart on Market share By Geographical Landscape2023-2028 (%)
Exhibits 70: Data Table on Market share By Geographical Landscape2023-2028 (%)
Exhibits 71: Chart on Geographic comparison
Exhibits 72: Data Table on Geographic comparison
Exhibits 73: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 74: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 78: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 82: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 90: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 91: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 94: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 95: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 98: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 102: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 103: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 106: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 109: Market opportunity By Geographical Landscape($ billion)
Exhibits 110: Data Tables on Market opportunity By Geographical Landscape($ billion)
Exhibits 111: Impact of drivers and challenges in 2023 and 2028
Exhibits 112: Overview on criticality of inputs and factors of differentiation
Exhibits 113: Overview on factors of disruption
Exhibits 114: Impact of key risks on business
Exhibits 115: Companies covered
Exhibits 116: Matrix on companies position and classification
Exhibits 117: AbbVie Inc. - Overview
Exhibits 118: AbbVie Inc. - Product / Service
Exhibits 119: AbbVie Inc. - Key news
Exhibits 120: AbbVie Inc. - Key offerings
Exhibits 121: Alvogen Iceland ehf - Overview
Exhibits 122: Alvogen Iceland ehf - Product / Service
Exhibits 123: Alvogen Iceland ehf - Key offerings
Exhibits 124: Amgen Inc. - Overview
Exhibits 125: Amgen Inc. - Product / Service
Exhibits 126: Amgen Inc. - Key offerings
Exhibits 127: Amneal Pharmaceuticals Inc. - Overview
Exhibits 128: Amneal Pharmaceuticals Inc. - Business segments
Exhibits 129: Amneal Pharmaceuticals Inc. - Key news
Exhibits 130: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits 131: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits 132: Bayer AG - Overview
Exhibits 133: Bayer AG - Business segments
Exhibits 134: Bayer AG - Key news
Exhibits 135: Bayer AG - Key offerings
Exhibits 136: Bayer AG - Segment focus
Exhibits 137: Bristol Myers Squibb Co. - Overview
Exhibits 138: Bristol Myers Squibb Co. - Product / Service
Exhibits 139: Bristol Myers Squibb Co. - Key news
Exhibits 140: Bristol Myers Squibb Co. - Key offerings
Exhibits 141: Eli Lilly and Co. - Overview
Exhibits 142: Eli Lilly and Co. - Product / Service
Exhibits 143: Eli Lilly and Co. - Key news
Exhibits 144: Eli Lilly and Co. - Key offerings
Exhibits 145: F. Hoffmann-La Roche Ltd. - Overview
Exhibits 146: F. Hoffmann-La Roche Ltd. - Product / Service
Exhibits 147: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibits 148: Ferring BV - Overview
Exhibits 149: Ferring BV - Product / Service
Exhibits 150: Ferring BV - Key offerings
Exhibits 151: GlaxoSmithKline Plc - Overview
Exhibits 152: GlaxoSmithKline Plc - Business segments
Exhibits 153: GlaxoSmithKline Plc - Key news
Exhibits 154: GlaxoSmithKline Plc - Key offerings
Exhibits 155: GlaxoSmithKline Plc - Segment focus
Exhibits 156: Johnson and Johnson Services Inc. - Overview
Exhibits 157: Johnson and Johnson Services Inc. - Business segments
Exhibits 158: Johnson and Johnson Services Inc. - Key news
Exhibits 159: Johnson and Johnson Services Inc. - Key offerings
Exhibits 160: Johnson and Johnson Services Inc. - Segment focus
Exhibits 161: Novartis AG - Overview
Exhibits 162: Novartis AG - Business segments
Exhibits 163: Novartis AG - Key news
Exhibits 164: Novartis AG - Key offerings
Exhibits 165: Novartis AG - Segment focus
Exhibits 166: Pfizer Inc. - Overview
Exhibits 167: Pfizer Inc. - Product / Service
Exhibits 168: Pfizer Inc. - Key news
Exhibits 169: Pfizer Inc. - Key offerings
Exhibits 170: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 171: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 172: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 173: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 174: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 175: Viatris Inc. - Overview
Exhibits 176: Viatris Inc. - Business segments
Exhibits 177: Viatris Inc. - Key news
Exhibits 178: Viatris Inc. - Key offerings
Exhibits 179: Viatris Inc. - Segment focus
Exhibits 180: Inclusions checklist
Exhibits 181: Exclusions checklist
Exhibits 182: Currency conversion rates for US$
Exhibits 183: Research methodology
Exhibits 184: Information sources
Exhibits 185: Data validation
Exhibits 186: Validation techniques employed for market sizing
Exhibits 187: Data synthesis
Exhibits 188: 360 degree market analysis
Exhibits 189: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global anti-inflammatory therapeutics market: AbbVie Inc., Alvogen Iceland ehf, Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Cadila Pharmaceuticals Ltd., Cipla Inc., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Ferring BV, GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Lupin Ltd., Viatris Inc., Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., and Novartis AG.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is emergence of novel anti-inflammatory drugs."

According to the report, one of the major drivers for this market is the increase in off-label use.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Alvogen Iceland ehf
  • Amgen Inc.
  • Amneal Pharmaceuticals Inc.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb Co.
  • Cadila Pharmaceuticals Ltd.
  • Cipla Inc.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Ferring BV
  • GlaxoSmithKline Plc
  • Johnson and Johnson Services Inc.
  • Lupin Ltd.
  • Viatris Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG